The potential of 4D's approach in curbing antimicrobial resistance among bacterial pathogens.
Microbial drug resistance
antimicrobial stewardship
antimicrobial susceptibility testing
dose
duration and de-escalation
optimal antibiotic therapy
right drug
Journal
Expert review of anti-infective therapy
ISSN: 1744-8336
Titre abrégé: Expert Rev Anti Infect Ther
Pays: England
ID NLM: 101181284
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
pubmed:
14
9
2022
medline:
26
10
2022
entrez:
13
9
2022
Statut:
ppublish
Résumé
Antibiotics are life-saving drugs but irrational/inappropriate use leads to the emergence of antibiotic-resistant bacterial superbugs, making their treatment extremely challenging. Increasing antimicrobial resistance (AMR) among bacterial pathogens is becoming a serious public health concern globally. If ignorance persists, there would not be any antibiotics available to treat even a common bacterial infection in future. This article intends to collate and discuss the potential of 4D's (right More efforts are needed for developing diagnostics for rapid, accurate, point-of-care, and cost-effective pathogen identification and antimicrobial susceptibility testing (AST) to facilitate rational use of antibiotics. Current dosing and duration of therapies also need to be redefined to maximize their impact. Furthermore, de-escalation approaches should be developed and encouraged in the clinic. This altogether will minimize selection pressure on the pathogens and reduce emergence of AMR.
Identifiants
pubmed: 36098225
doi: 10.1080/14787210.2022.2124968
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM